Sanbe Tears

Quick links to important sections

Sanbe Tears

Method of action: Ophthalmologicals

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sanbe Tears

Property Description
Active Ingredients Polyvinyl Alcohol (PVA) and Povidone
Form Ophthalmic solution (eye drops)
Pharmacological Class Ophthalmic Demulcents
Common Use Temporary relief of dry eye irritation
Regulatory Status Over-the-counter (OTC)
Manufacturer Focus Santen (Ophthalmic specialist)

Sanbe Tears is an over-the-counter (OTC) product classified as an ocular lubricant or artificial tears. This formulation is specifically designed for the temporary relief of symptoms associated with dry eye syndrome, such as burning, irritation, and discomfort due to environmental factors like wind or prolonged screen use.

The product's efficacy is grounded in the established combination of Polyvinyl Alcohol (PVA) and Povidone as its active ingredients. These polymers are recognized as ophthalmic demulcents. Both PVA and Povidone are established demulcent agents for use in OTC ophthalmic products, supporting the general effectiveness of these ingredients in eye care.

The combination of PVA and Povidone is utilized for its benefit in relieving dry eye symptoms. The product's design is intended to supplement the natural tear film by mimicking the protective and lubricating properties of the eye's natural mucin layer. This provides immediate comfort without treating the underlying cause of dry eye.

What side effects are possible with Sanbe Tears?

Possible Side Effects and Safety Information

The safety profile for Sanbe Tears, an ophthalmic solution containing Polyvinyl Alcohol and Povidone, is documented in official regulatory labeling, defining both expected reactions and conditions that require professional review. The information presented here is based strictly on government regulatory sources.


Documented Ocular Adverse Effects

The adverse reactions documented in the regulatory labeling are primarily localized to the Eye Disorders system. These effects are typically temporary and may occur immediately following application. They include transient blurred vision, minor stinging, burning, or general irritation of the eye .


Serious Safety Endpoints and Restrictions

The official labeling defines specific safety signals that necessitate stopping use and seeking professional medical evaluation. These serious adverse reaction indicators include the onset of eye pain, any significant changes in vision, or continued redness or irritation of the eye. Irritation or redness that worsens or persists for a duration exceeding 72 hours is explicitly defined as a safety concern.

Safety Restrictions: The solution must not be used by individuals with known hypersensitivity to any ingredient. It is also restricted from use if the solution changes color or appears cloudy.


Population-Specific Safety Considerations

Regulatory documents include specific notes for certain user groups. Pregnant or breast-feeding individuals are required to consult a health professional before using the product. Furthermore, the product must be stored out of the reach of children, and immediate medical attention is required if accidental swallowing occurs due to the potential for systemic harm.

Overdose and Emergency Response

Overdose and When to Seek Help

The overdose profile for Sanbe Tears (Polyvinyl Alcohol and Povidone Ophthalmic Solution) is defined by its topical route of administration and low systemic risk. Because the active demulcent ingredients exhibit negligible systemic absorption, severe systemic clinical manifestations of overdose from placing excess solution in the eye are not documented in official regulatory sources.

Regulatory guidance for overdose focuses on the action required following accidental ingestion of the solution.

Official Regulatory Directives

  • No systemic signs or symptoms of overdose are formally documented in official regulatory labeling for this ophthalmic product.
  • Immediate medical help is required if the product is accidentally swallowed.
  • The regulatory text mandates that the patient contact a Poison Control Center right away if the solution is swallowed.
  • No specific antidote is known or documented for overdose with this solution.
  • Symptomatic and supportive treatment is the implied management, as medical procedures are not detailed in the official labeling.

Regulatory authorities define the emergency-seeking condition by the necessity for professional management in the event of accidental oral ingestion, rather than anticipated toxicity from topical overuse.

Therapeutic Uses of Sanbe Tears

What Sanbe Tears Treats: Main Uses and Benefits

The primary therapeutic area for Sanbe Tears is the symptomatic relief associated with dry eyes and ocular surface irritation. These products are commonly used in the initial symptomatic management of dry eye and are intended for easing the symptoms that patients experience.

This medication is commonly used to help with a cluster of symptoms that interfere with daily functioning, including grittiness, burning, stinging, and the sensation of a foreign body in the eye. It is applied in addressing temporary dryness caused by environmental factors or prolonged visual focus, such as extensive screen work or exposure to wind and dry air.

The medication provides support that helps ease the overall symptom burden and contributes to improved comfort during periods of heightened symptoms. It may assist in easing the associated minor redness and eye strain by providing the necessary short-term symptomatic assistance.

“This supportive relief provides assistance when symptoms interfere with routine activities.”

Quick Fact: Relief for Dryness and Irritation

Eligibility and Restrictions for Use

Eligibility Scope for Sanbe Tears

The eligibility for using Sanbe Tears, an over-the-counter (OTC) ophthalmic demulcent, is defined by official regulatory documentation that focuses on absolute prohibitions and conditional restrictions.

Scope Item Official Regulatory Statement
Populations for whom use is allowed Use is permitted for the general adult population and children aged 6 years and older under the standard OTC labeling conditions.
Populations for whom use is contraindicated The product is contraindicated for individuals with a known hypersensitivity or allergy to Polyvinyl Alcohol, Povidone, or any other ingredient in the formulation.
Age-related eligibility rules Use in children under 6 years of age is restricted; the official labeling directs that a health professional must be consulted before use.
Pregnancy and lactation eligibility status Conditional Use applies to individuals who are pregnant or breast-feeding; the labeling mandates that a health professional must be asked before starting use.
Eligibility-related restrictions The product must not be used if the solution changes color or becomes cloudy. Contact lenses must be removed prior to application.
Conditions defining when to stop use All users must stop use and seek medical advice if they experience eye pain, changes in vision, continued redness, or irritation that worsens or persists for more than 72 hours.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Sanbe Tears, which contains the ophthalmic demulcents Polyvinyl Alcohol and Povidone, is characterized by a minimal risk of systemic drug interactions. This is due to the product's topical application and subsequent negligible systemic absorption, a property reflected in regulatory monographs.

Documented Interaction Profile

Interaction Category Regulatory Status
Systemic Drug-Drug Interactions None documented
Food, Alcohol, or Herbal Interactions None documented
Metabolic/Transporter Interactions None documented

Pharmacodynamic and Administration Restrictions

Interaction documentation focuses exclusively on local pharmacodynamic interference with other topical ophthalmic preparations. The co-administration of this product with other eye drops, suspensions, or ointments can result in the dilution and washout of the concurrently administered medicine, thereby reducing its effective ocular surface exposure.

To prevent this documented interaction, regulatory labeling mandates a timing separation between the instillation of this product and any other eye medicine. This procedural constraint requires administering other topical ophthalmic solutions at least 5 to 15 minutes apart. Official regulatory documents do not specify any interaction requirements pertaining to systemic medicines or specific patient populations.

Mechanism of Action

Sanbe Tears, which typically contains Hypromellose (Hydroxypropyl Methylcellulose, HPMC) as a polymeric component, operates through a physical-chemical mechanism on the ocular surface. The polymer functions as a demulcent and viscosity-enhancing agent. Upon ocular instillation, the hydrophilic, viscoelastic polymer forms a colloid solution that coats the corneal and conjunctival epithelia. This interaction physically modifies the precorneal tear film, primarily by increasing the viscosity of the aqueous layer. The augmented viscosity prolongs the residence time of the solution on the ocular surface. This physical coating enhances the stability of the overall tear film structure. The mechanical consequence of this action is the stabilization and thickening of the precorneal layer, leading to prolonged tear film breakup time. There are no known direct ligand-receptor binding events or intracellular second messenger cascades involved in the primary mechanism of action of HPMC at the cellular level; its effects are predominantly systemic, providing structural, non-pharmacological modulation of the ocular surface lubrication and wetting characteristics.

Dosage and Administration Information

Sanbe Tears is an ophthalmic solution for topical use that is administered directly to the surface of the eye. The usage pattern for the Polyvinyl Alcohol and Povidone combination is symptom-contingent, meaning it is used intermittently rather than on a fixed, scheduled regimen. The standard application involves instilling 1 or 2 drops into the affected eye(s). This product is designated exclusively for temporary relief, reflecting a use duration based on acute episodes of dryness.

Administration Principles

Feature Usage Guideline
Dosing Frequency Administered as needed for relief.
Administration Route Topical Ophthalmic only.
Dose Volume 1 or 2 drops per use.
Procedural Constraint Contact lenses must be removed before use.

The proper use protocol includes several key procedural steps to ensure correct delivery. Prior to administration, patients must visually check the solution; it should not be used if it has changed color or appears cloudy. Furthermore, strict attention to sterility is required, prohibiting the container tip from touching the eye or any other surface during the instillation process. Regarding age-specific populations, use in children under 6 years of age warrants consultation with a healthcare professional. These steps outline the general usage protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Sanbe Tears

Evidence Supporting Temporary Symptom Relief

The active components in Sanbe Tears, Polyvinyl Alcohol (PVA) and Povidone, were studied for their role as ophthalmic demulcents, which are agents that were studied for their role in surface lubrication. The official regulatory classification for these ingredients comes from a wide body of evidence, including historical data and clinical research, which has led regulatory bodies to classify them for their intended use as demulcents. This research base includes various pharmacological studies and short-term Randomized Controlled Trials (RCTs) that have explored outcomes related to physical discomfort in adult patients.

The findings describe patterns observed in the studies related to temporary, episodic symptoms such as irritation, burning, and the feeling of a foreign body in the eye. Studies reported measurements of changes in patient-reported discomfort using scales designed to assess perceived discomfort. This evidence contributes to understanding symptom patterns and provides context for the product’s intended use in conditions characterized by fluctuating or episodic manifestations.

Regulatory Foundation and Study Outcomes Examined

The evidence base relies on the formal recognition of its active components within the Over-the-Counter (OTC) Monograph, which reviewed the data for their use as demulcents. Research examined how symptoms change over time in patients with conditions involving periods of heightened symptoms. Studies explored the effects on functional measures of the eye, such as the tear film breakup time (TBUT), which monitors physiological strain or stress.

Long-Term Evidence and Duration of Follow-up

Studies were relevant in trials assessing short-term or episodic symptom patterns and often focused on observation periods lasting up to a few weeks. While short-term evidence is available, long-term effects are not fully established. Research provides context but not individual predictions for use over several months or years.

What Research Gaps Remain Uncharted

Research for these active ingredients highlights certain areas where the evidence is limited. The studies monitored symptoms but were not designed to assess modification to the underlying dry eye condition itself. Comparative evidence among different non-medicated artificial tear formulations is lacking or findings were mixed across comprehensive reviews. The results apply only to the populations studied, meaning the research does not determine whether an individual outside these specific groups will respond similarly.

Key Studies & References Polyvinyl alcohol and povidone ophthalmic solution (TEARS NATURALE® II) in the management of dry eye.

Frequently Asked Questions (FAQ)

Common questions about Sanbe Tears (FAQ)


Q: Are there any reported side effects related to blurred vision?

Official product labeling documents list transient blurred vision as an ocular side effect that may occur temporarily following the application of the drops. This means that your vision may become temporarily unclear right after you put the drops in your eye. This effect is generally expected to resolve quickly as the solution settles on the ocular surface.


Q: What is the difference between the single-use vials and the multi-dose bottle?

The main difference between the two dosage forms relates to the maintenance of sterility over time. Multi-dose bottles usually contain a preservative to keep the solution clean for a set period after opening. Single-use vials are generally preservative-free. Users often check the specific product label to see if a preservative-free version is available.


Q: What are common patient expectations for using Sanbe Tears?

The product is officially classified and designed for the temporary relief of symptoms related to dry eye, such as burning or irritation. The official evidence base supports an expectation of short-term, episodic improvement in these physical discomforts, rather than long-term condition modification.


Q: Is it normal to feel a temporary sticky sensation after applying Sanbe Tears?

The demulcent ingredients in this formulation are intended to increase the solution's viscosity, which means they create a thicker coating. This physical action on the eye surface is what provides lubrication and may be perceived by some users as a temporary sticky sensation or a feeling of a foreign body in the eye.


Q: How long does the lubricating effect of Sanbe Tears usually last?

Official documents classify the product for temporary relief of symptoms. The physical mechanism of the active ingredients is intended to prolong the retention time of the solution on the ocular surface. A specific duration, measured in minutes or hours, is not stated in the regulatory labeling for the lubricating effect.


Q: Is Sanbe Tears the same as artificial tears or eye drops?

Sanbe Tears is formally classified by regulators as an Ophthalmic Solution, which is a type of eye drop. Its active components are categorized as Ocular Demulcents, which is the specific class of ingredients commonly used in products often referred to by the general public as 'artificial tears' or 'eye lubricants.'


Q: Does Sanbe Tears contain preservatives?

The inclusion of a preservative depends on the exact form of the product. Multi-dose bottles generally include a preservative to maintain sterility. Users with sensitive eyes or those who use the drops frequently often check the label to determine if a preservative-free version is needed.


Q: How quickly should I expect to feel a difference after using Sanbe Tears?

Since the product is classified for the temporary relief of symptoms, the physical coating mechanism suggests the effect may be noticeable soon after application. The demulcents work by instantly coating the eye surface to provide lubrication.


Q: Is there a generic version of Sanbe Tears available?

The active ingredients in Sanbe Tears, Polyvinyl Alcohol and Povidone, are both recognized components in the Over-the-Counter (OTC) Monograph for ophthalmic demulcents. Because of this classification, the exact combination of these active ingredients is widely available in many generic and store-brand ophthalmic solutions.


Q: Why do some people say Sanbe Tears stings a little when they first use it?

Official product information lists minor stinging or burning as a common, transient side effect that is associated with the initial application of the drops. This is a recognized temporary effect documented in the product's adverse reactions section.


Q: Are there any known interactions between Sanbe Tears and common over-the-counter pain relievers?

Regulatory documents confirm that there are no known systemic drug-drug interactions between Sanbe Tears and common oral over-the-counter (OTC) pain relievers. This is because the product is applied topically to the eye, resulting in negligible absorption into the body's system.


Q: Do other eye conditions besides dry eye use Sanbe Tears?

The official indication for this product is for the temporary relief of symptoms such as irritation, burning, and discomfort. These symptoms can be associated with a variety of minor ocular irritations that may or may not be diagnosed as specific dry eye syndrome.


Q: Does Sanbe Tears help with redness or only dryness?

The product’s primary intended use is for the relief of dryness, burning, and irritation. It is important to know that continued or worsened redness of the eye is explicitly listed in official safety warnings as a signal to stop use and seek professional medical evaluation.


Q: Does Sanbe Tears have any known food or alcohol interactions?

Official regulatory documents state that there are no documented interactions between Sanbe Tears and food, alcohol, or herbal products. This is consistent with its topical application and minimal systemic absorption.


Q: What do official sources say about the safety of Sanbe Tears for older adults?

Official regulatory guidelines indicate that the use of this product in older adults is not expected to result in different side effects or complications compared to its use in younger adults.


Q: What is the purpose of the inactive ingredients in Sanbe Tears?

Inactive ingredients serve several crucial roles, primarily ensuring the product's safety and comfort. They are included to help the solution match the natural salt and pH balance of the eye's tears. They also ensure that the ophthalmic solution remains stable and sterile for use.


Q: Do any official documents discuss long-term safety data for Sanbe Tears?

The evidence base for the active ingredients focuses on their effects in short-term or episodic use. Official documentation indicates that long-term safety and effects over periods of several months or years are not fully established by the existing research base.


Q: Can I use Sanbe Tears for eye strain from computer use?

The official use includes the temporary relief of symptoms due to environmental factors such as wind or exposure from prolonged computer use. The product is indicated for the temporary relief of resulting dryness and irritation.


Q: Are Sanbe Tears drops suitable for sensitive eyes?

For individuals who identify as having sensitive eyes, official information sometimes suggests looking for a version of the product that is preservative-free. This is because preservatives in multi-dose bottles can sometimes be a source of increased irritation for some users.


Q: What regulatory class does Sanbe Tears fall under (e.g., medical device, drug)?

Sanbe Tears is classified by regulatory bodies as an Over-the-Counter (OTC) Human Drug. It belongs to the specific pharmacological class of Ophthalmic Demulcents, which are ingredients used as ocular lubricants.


Q: Can Sanbe Tears affect driving or operating machinery?

Official precautions state that vision may be temporarily blurred immediately after the product is administered. Users should be aware that official precautions state they should not drive or use machinery until their vision is clear and they can do so safely.

How should Sanbe Tears be stored and disposed of?

How to Store and Dispose of Sanbe Tears

Sanbe Tears (Polyvinyl Alcohol / Povidone) must be stored under specific conditions to maintain its sterility and effectiveness, as defined by regulatory documents.

Storage Requirements

The solution must be stored at room temperature, typically between 15 C and 25 C. To prevent contamination, the bottle must be kept tightly closed, and the dropper tip must not touch any surface. The product must also be stored out of reach of children.

Stability and Disposal

Once opened, the multi-dose container has a time-limited stability period. The contents must be discarded four weeks (28 days) after opening. If the solution changes color or becomes cloudy, it must not be used. For disposal of unused or expired medicine, follow the guidance of a pharmacist or consult local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sanbe Tears found in:

A-Z Index: